Similar articles for PMID: 29507103

Year	Number of Results
2007	1
2008	2
2009	1
2011	3
2012	3
2013	6
2014	6
2015	14
2016	12
2017	11
2018	6
2019	2
2020	3
2024	0

1

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach.

Cuadrado A, Manda G, Hassan A, Alcaraz MJ, Barbas C, Daiber A, Ghezzi P, León R, López MG, Oliva B, Pajares M, Rojo AI, Robledinos-Antón N, Valverde AM, Guney E, Schmidt HHHW. Cuadrado A, et al. Pharmacol Rev. 2018 Apr;70(2):348-383. doi: 10.1124/pr.117.014753. Pharmacol Rev. 2018. PMID: 29507103 Free article. Review.

2

NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases.

Cores Á, Piquero M, Villacampa M, León R, Menéndez JC. Cores Á, et al. Biomolecules. 2020 Jun 14;10(6):904. doi: 10.3390/biom10060904. Biomolecules. 2020. PMID: 32545924 Free PMC article. Review.

3

Nrf2, the Master Regulator of Anti-Oxidative Responses.

Vomund S, Schäfer A, Parnham MJ, Brüne B, von Knethen A. Vomund S, et al. Int J Mol Sci. 2017 Dec 20;18(12):2772. doi: 10.3390/ijms18122772. Int J Mol Sci. 2017. PMID: 29261130 Free PMC article. Review.

4

Directly interact with Keap1 and LPS is involved in the anti-inflammatory mechanisms of (-)-epicatechin-3-gallate in LPS-induced macrophages and endotoxemia.

Chiou YS, Huang Q, Ho CT, Wang YJ, Pan MH. Chiou YS, et al. Free Radic Biol Med. 2016 May;94:1-16. doi: 10.1016/j.freeradbiomed.2016.02.010. Epub 2016 Feb 12. Free Radic Biol Med. 2016. PMID: 26878775

5

Nrf2 in health and disease: current and future clinical implications.

Al-Sawaf O, Clarner T, Fragoulis A, Kan YW, Pufe T, Streetz K, Wruck CJ. Al-Sawaf O, et al. Clin Sci (Lond). 2015 Dec;129(12):989-99. doi: 10.1042/CS20150436. Clin Sci (Lond). 2015. PMID: 26386022 Review.

6

Targeting Nrf2 in Protection Against Renal Disease.

Guerrero-Hue M, Farre-Alins V, Palomino-Antolin A, Parada E, Rubio-Navarro A, Egido J, Egea J, Moreno JA. Guerrero-Hue M, et al. Curr Med Chem. 2017;24(33):3583-3605. doi: 10.2174/0929867324666170511120814. Curr Med Chem. 2017. PMID: 28494744 Review.

7

Nrf2 as a therapeutic target for rheumatic diseases.

Ferrándiz ML, Nacher-Juan J, Alcaraz MJ. Ferrándiz ML, et al. Biochem Pharmacol. 2018 Jun;152:338-346. doi: 10.1016/j.bcp.2018.04.010. Epub 2018 Apr 13. Biochem Pharmacol. 2018. PMID: 29660314 Free article. Review.

8

Nrf2 Is an Attractive Therapeutic Target for Retinal Diseases.

Nakagami Y. Nakagami Y. Oxid Med Cell Longev. 2016;2016:7469326. doi: 10.1155/2016/7469326. Epub 2016 Oct 12. Oxid Med Cell Longev. 2016. PMID: 27818722 Free PMC article. Review.

9

Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation.

Hybertson BM, Gao B, Bose SK, McCord JM. Hybertson BM, et al. Mol Aspects Med. 2011 Aug;32(4-6):234-46. doi: 10.1016/j.mam.2011.10.006. Epub 2011 Oct 15. Mol Aspects Med. 2011. PMID: 22020111 Free article. Review.

10

Identification of Non-Electrophilic Nrf2 Activators from Approved Drugs.

Zhang QY, Chu XY, Jiang LH, Liu MY, Mei ZL, Zhang HY. Zhang QY, et al. Molecules. 2017 May 26;22(6):883. doi: 10.3390/molecules22060883. Molecules. 2017. PMID: 28587109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

59 results

Results by year